%0 Journal Article
%T Molecular diagnostics for congenital hearing loss including 15 deafness genes using a next generation sequencing platform
%A Sarah De Keulenaer
%A Jan Hellemans
%A Steve Lefever
%A Jean-Pierre Renard
%A Joachim De Schrijver
%A Hendrik Van de Voorde
%A Mohammad Amin Tabatabaiefar
%A Filip Van Nieuwerburgh
%A Daisy Flamez
%A Filip Pattyn
%A Bieke Scharlaken
%A Dieter Deforce
%A Sofie Bekaert
%A Wim Van Criekinge
%A Jo Vandesompele
%A Guy Van Camp
%A Paul Coucke
%J BMC Medical Genomics
%D 2012
%I BioMed Central
%R 10.1186/1755-8794-5-17
%X In this proof of concept study, we screened 15 autosomal recessive deafness genes in 5 patients with congenital genetic deafness. 646 specific primer pairs for all exons and most of the UTR of the 15 selected genes were designed using primerXL. Using patient specific identifiers, all amplicons were pooled and analyzed using the Roche 454 NGS technology. Three of these patients are members of families in which a region of interest has previously been characterized by linkage studies. In these, we were able to identify two new mutations in CDH23 and OTOF. For another patient, the etiology of deafness was unclear, and no causal mutation was found. In a fifth patient, included as a positive control, we could confirm a known mutation in TMC1.We have developed an assay that holds great promise as a tool for screening patients with familial autosomal recessive nonsyndromal hearing loss (ARNSHL). For the first time, an efficient, reliable and cost effective genetic test, based on PCR enrichment, for newborns with undiagnosed deafness is available.
%K Deafness
%K Next generation sequencing
%K PCR based enrichment
%K Genetic diagnostics
%U http://www.biomedcentral.com/1755-8794/5/17/abstract